DVANYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
DAVITA INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$187.00−0.31 (-0.17%)
Close on Oct 19, 2026
- Market cap
- $12.36B
- P/E (TTM)
- 15.3
- Dividend yield
- –
DAVITA INC. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U S Dialysis And Related Lab Services with Intersegment | $3.01B | $2.94B | – | $2.98B | $2.91B | $2.82B | – | $2.91B | $2.84B | – | – | – | 84.7% | +3.4% |
| U. S. Dialysis And Related Lab Services | $3.00B | $2.92B | – | $2.97B | $2.90B | $2.81B | – | $2.89B | $2.83B | – | – | – | 84.4% | +3.6% |
| Other Operating Segments with Intersegment | $556.71M | $497.61M | $566.89M | $454.89M | $485.69M | $414.82M | $430.10M | $376.33M | $362.46M | $341.61M | – | – | 15.7% | +14.6% |
| Other - Ancillary Services | $553.62M | $494.32M | $564.02M | $452.12M | $482.85M | $412.09M | $425.36M | $373.73M | $358.64M | $338.86M | $358.35M | $360.32M | 15.6% | +14.7% |
| U S Dialysis | – | – | – | – | – | $2.81B | $2.82B | $2.91B | $2.84B | $2.73B | $2.72B | $2.79B | – | – |
| U S Dialysis And Related Lab Services with Intersegment | – | – | – | – | – | $2.82B | – | – | – | $2.76B | – | – | – | – |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U. S. Dialysis And Related Lab Services | $537.98M | $505.97M | – | $530.11M | $522.84M | $475.77M | – | $549.48M | $550.19M | – | – | – | +2.9% |
| Other - Ancillary Services | $57.05M | $5.83M | $37.25M | $1.22M | $56.71M | -$2.81M | $98.85M | $13.91M | -$18.59M | -$11.50M | $9.63M | $28.10M | +0.6% |
| U S Dialysis | – | – | – | – | – | $475.77M | $495.61M | $549.48M | $550.19M | $525.74M | $443.59M | $509.14M | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Davita's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.